WELLINGTON, July 29 (Reuters) - New Zealand's health regulator Medsafe has granted provisional approval for the AstraZeneca COVID-19 vaccine for individuals 18 years of age and older, acting minister for COVID-19 response, Dr Ayesha Verrall, said on Thursday.
New Zealand secured 7.6 million doses of the AstraZeneca AZN.L COVID-19 vaccine through an advance purchase agreement with the company last year.
The country has only been using the Pfizer/BioNTech COVID-19 vaccine so far. (([email protected]; +6448028163; Reuters Messaging: [email protected]; Twitter: https://twitter.com/Journopraveen))
